Healthcare Practice Lead
Jennifer O’Neill has been leading integrated communications programs for pharma and biotech for 20 years.
During her career, she’s worked across all phases of the product lifecycle and has extensive experience counseling some of the world’s most well-known healthcare brands. Jennifer has worked in all major therapeutic areas including rare disease, CNS, cardiology, immunology, mental health, pain, diabetes, infectious disease and dermatology.
Jennifer’s work spans the gamut from scientific data communications, FDA approvals, regulatory actions, advisory committees and launching multi-year consumer and franchise-driven platforms. She has extensive issues management experience and has honed a strong point-of-view on aligning stakeholders in today’s pressure-driven environment that surrounds our clients daily.
Most recently Jennifer worked across the biopharmaceutical commercial spectrum as Vice President, Commercial Business Development at inVentiv Health. Her team was responsible for launching and building the Company’s Contract Commercial Organization, or CCO – the first of its kind. In this role, she supported C-suite executives in bringing innovative molecules to market with business, infrastructure and strategic brand solutions. Also, during her tenure at inVentiv, Jennifer served as Managing Director of Chamberlain Healthcare Public Relations, a leading science-driven global healthcare public relations firm. She joined the Chamberlain team in 2004 as Vice President to lead some of the agency’s largest accounts and then spent over a decade growing the agency, its teams and culture.
Earlier in her career, she served as senior counsel in both the Healthcare and Corporate Communications divisions of Ruder Finn.
Jennifer’s programs have been recognized by several industry awards such as SABREs, MM&Ms, Big Apples, Silver and Bronze Anvils, Clio, Spokesperson of the Year, Hermes Creative Awards and PhAME. She is a graduate of Dickinson College where she earned a Bachelor of Arts in Psychology.